Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Anagnostouli

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Spastic paretic hemifacial contracture in multiple sclerosis: a neglected clinical and EMG entityG Koutsis, P Kokotis, P Sarrigiannis, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Determination of biotin levels in cerebrospinal fluid samplesE Livaniou, J O Nyalala, M Anagnostouli, et al.
Acta Neurologica Scandinavica|November 30, 1999
Cerebrospinal fluid levels of biotin in various neurological disordersM Anagnostouli, E Livaniou, J O Nyalala, et al.
Acta Neurologica Scandinavica|June 18, 2002
Thyroid gland neurofibroma in a NF1 patientM Anagnostouli, G Piperingos, C Yapijakis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 15, 2003
Campylobacter jejuni O:19 serotype-associated Guillain-Barré syndrome in a child: the first case reported from GreeceS Chatzipanagiotou, K Kilidireas, G Trimis, et al.
Journal of the Neurological Sciences|December 1, 2005
IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosisM Rentzos, C Cambouri, A Rombos, et al.
Clinical Neurology and Neurosurgery|October 6, 2005
Serum uric acid and multiple sclerosisM Rentzos, C Nikolaou, M Anagnostouli, et al.
International Journal of Cardiology|October 10, 2015
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmasE Gialafos, E Andreadou, P Kokotis, et al.
Journal of the Neurological Sciences|December 27, 2016
Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-upM E Evangelopoulos, E Andreadou, G Koutsis, et al.
BMC Neurology|November 3, 2020
Heterogeneity of Baló's concentric sclerosis: a study of eight cases with different therapeutic conceptsD Tzanetakos, A G Vakrakou, J S Tzartos, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Spastic paretic hemifacial contracture in multiple sclerosis: a neglected clinical and EMG entityG Koutsis, P Kokotis, P Sarrigiannis, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Determination of biotin levels in cerebrospinal fluid samplesE Livaniou, J O Nyalala, M Anagnostouli, et al.
Acta Neurologica Scandinavica|November 30, 1999
Cerebrospinal fluid levels of biotin in various neurological disordersM Anagnostouli, E Livaniou, J O Nyalala, et al.
Acta Neurologica Scandinavica|June 18, 2002
Thyroid gland neurofibroma in a NF1 patientM Anagnostouli, G Piperingos, C Yapijakis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 15, 2003
Campylobacter jejuni O:19 serotype-associated Guillain-Barré syndrome in a child: the first case reported from GreeceS Chatzipanagiotou, K Kilidireas, G Trimis, et al.
Journal of the Neurological Sciences|December 1, 2005
IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosisM Rentzos, C Cambouri, A Rombos, et al.
Clinical Neurology and Neurosurgery|October 6, 2005
Serum uric acid and multiple sclerosisM Rentzos, C Nikolaou, M Anagnostouli, et al.
International Journal of Cardiology|October 10, 2015
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmasE Gialafos, E Andreadou, P Kokotis, et al.
Journal of the Neurological Sciences|December 27, 2016
Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-upM E Evangelopoulos, E Andreadou, G Koutsis, et al.
BMC Neurology|November 3, 2020
Heterogeneity of Baló's concentric sclerosis: a study of eight cases with different therapeutic conceptsD Tzanetakos, A G Vakrakou, J S Tzartos, et al.
Pageof 2